Healthcare provider profile · identity verified

Rewaida Hall, MD

Internal Medicine · COLORADO SPRINGS, CO · NPI 1902426166

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	216	90
Levothyroxine Sodium	Levothyroxine Sodium	164	58
Gabapentin	Gabapentin	123	49
Amlodipine Besylate	Amlodipine Besylate	118	40
Lisinopril	Lisinopril	113	37
Metformin Hcl	Metformin Hcl	108	38
Losartan Potassium	Losartan Potassium	95	35
Trazodone Hcl	Trazodone Hcl	80	30
Rosuvastatin Calcium	Rosuvastatin Calcium	71	29
Sertraline Hcl	Sertraline Hcl	63	21
Famotidine	Famotidine	60	26
Alendronate Sodium	Alendronate Sodium	59	23
Duloxetine Hcl	Duloxetine Hcl	55	21
Simvastatin	Simvastatin	54	17
Trulicity	Dulaglutide	54	12
Tamsulosin Hcl	Tamsulosin Hcl	52	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	19
Metoprolol Succinate	Metoprolol Succinate	50	19
Omeprazole	Omeprazole	50	21
Allopurinol	Allopurinol	47	15
Januvia	Sitagliptin Phosphate	45	15
Bupropion Xl	Bupropion Hcl	44	11
Pantoprazole Sodium	Pantoprazole Sodium	44	17
Albuterol Sulfate Hfa	Albuterol Sulfate	43	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	12
Celecoxib	Celecoxib	40	15
Eliquis	Apixaban	39	15
Mounjaro	Tirzepatide	39	suppressed
Potassium Chloride	Potassium Chloride	37	21
Zolpidem Tartrate	Zolpidem Tartrate	37	13
Hydrochlorothiazide	Hydrochlorothiazide	34	12
Fluticasone Propionate	Fluticasone Propionate	33	14
Carvedilol	Carvedilol	32	15
Metoprolol Tartrate	Metoprolol Tartrate	31	11
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	14
Labetalol Hcl	Labetalol Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Jardiance	Empagliflozin	25	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	25	suppressed
Furosemide	Furosemide	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Ozempic	Semaglutide	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Valsartan	Valsartan	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	11
Montelukast Sodium	Montelukast Sodium	19	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Trintellix	Vortioxetine Hydrobromide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Atenolol	Atenolol	15	suppressed
Finasteride	Finasteride	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Ramipril	Ramipril	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error